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28Abstract This study describes the protective effects of piperazine derived compounds against aspi-
rin induced gastric injuries and evaluated the role of nitric oxide, inﬂammatory cytokines and serum
level of aspartate aminotransaminases (AST), alanine aminotransaminases (ALT), high density
lipoprotein (HDL) and malondialdehyde (MDA). The oral administration of the compounds at
doses 30 and 60 mg/kg protected the gastric against the nectrotizing effects of aspirin. The level
of nitric oxide (NO) was elevated in the group pretreated with the compounds. The results also
showed that pre-treatment with piperazine compounds has led to the decrease in the amount of
MDA and increased the activity of AST, ALT and HDL. In conclusion, pre-treatment with piper-
azine derived compounds; (E)-2-(1-(2-(piperazin-1-yl)ethylimino)ethyl)phenol (2HP), (E)-4-(1-(2-
(piperazin-1-yl)ethylimino)ethyl) benzene-1,3-diol (DHP) and their zinc complexes has provided a
signiﬁcant protection to the gastric from damaging effects of aspirin.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.niversity of Malaya, Depart-
r, Shah Alam, Malaysia. Tel.:
m (M.S. Salga).
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ethylimino)ethyl)benzene-1,3-diol Schiﬀ ba1. Introduction
The therapeutic potencies of the non-steroidal anti-inﬂamma-
tory drugs (NSAID) such as prophylaxis of cardiovascular
events, conversion of fever and pains associated with common
cold, arthritis and acute rheumatism have been reported
(Bertagnolli, 2003; Monnier et al., 2005). Aspirin, one of theing Saud University.
vities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl) ethylimi-
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2 M.S. Salga et al.famous NSAID has been frequently used as an analgesic to re-
lieve minor aches, effective in the treatment of patients with
aspirin exacerbated respiratory diseases (AERD) and many
forms of cancer except for prostate cancer (Vane, 1971).
Administration of aspirin in long-term at low doses to people
at high risk of developing blood clots has been found to pre-
vent heart attacks, strokes and blood clot formation (Patrono,
1994; Ridker et al., 1997). Apart from the health beneﬁts
attributed to aspirin, substantial gastric sphacelus had been
noticed in many studies. Some of the unwanted side effects
of aspirin involved tinnitus, gastrointestinal and stomach
bleedings particularly in high doses. The ability of aspirin to
restrain the production of prostaglandin and thromboxanes
was due to its non selective inhibition of the enzyme cycloox-
ygenase by acting as acetylating agent and covalently binding
to serine residue in the active site of enzyme (PTGS), or it buf-
fers and transports proton (Smith and Willis, 1971). Moreover,
the effects of aspirin involved inhibition of growth factor, inﬁl-
tration of neutrophils and elevation of cytokines (Choi et al.,
2010).
Recent study suggests that the cytokines such as tumor
necrosis factor-alpha (TNF-a), interleukin-6 (IL-6) and inter-
leukin-10 (IL-10) play important roles in the acute phase
inﬂammation as well as in safeguarding and controlling the
severity of gastric ulcers (Salga et al., 2011). Piperazine com-
pounds have found substantial pharmaceutical applications
such as anthelmintic for the treatment of worms like ascariasis,
enterobiasis, and oxyriasis, acyl piperazine is useful as an anti-
inﬂammatory agent for the treatment of inﬂammatory disor-
ders in human (Gauthier et al., 1996). Moreover, N-benzylpip-
erazines (BPZ) are also used as active ingredients in
recreational pills commonly used to provide stimulant eupho-
ric effect similar to that of methylenedioxymethanphetamine
(MDMA) ecstasy. BPZ predominantly affects dopamine trans-
mission but the exact mechanism of action is still unknown
(Johnstone et al., 2007). Zinc on the other hand, played an
important role in cell-mediated immune functions and in chil-
dren growth, it was also considered as a cofactor for metallo-
enzymes, superoxide dismutase, (SOD) collagenase, alcohol
dehydrogenase and spermatogenesis. It is required for the
proper functioning of mucosal cells and it protects gastrointes-
tinal diseases by acting as an antioxidant and anti-
inﬂammatory agent. Furthermore, zinc deﬁciency leads to
poor wound healing, loss of taste and smell and causes eleva-
tion of reactive oxygen species (ROS) (Tuormaa, 1995). This
study therefore, was aimed at synthesizing for the ﬁrst time,
the zinc complexes derived from 2-(ketoiminoethyl)piperazine
Schiff bases and evaluate their possible gastro-protective
efﬁcacies against aspirin induced ulceration using omeprazole
as reference drug.2. Materials and methods
2.1. Materials
The chemicals 1-(2-hydroxyphenyl)ethanone, 1-(2,4-
dihydroxyphenyl)ethanone, zinc(II) chloride hydrate, solvents
and other reagents were of analytical grade and are purchased
from Merck–Aldrich, Kuala Lumpur, Malaysia. Mass spectra
were recorded on Maldi-TOF/TOF-ESI mass spectra. CHN
analysis was carried out on Costech Elemental CombustionPlease cite this article in press as: Salga, M.S. et al., Synthesis and gastroprotective acti
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on ECA-400 higher-performance FT-NMR Spectrophotome-
ter. IR spectra were obtained from Perkin-Elmer FTIR Spec-
trophotometer. UV–visible spectroscopy was conducted on
Perkin-Elmer-1650-UV–visible spectrophotometer; TGA was
recorded on TGA-3000 thermo-analyzer.
2.2. Methods
2.2.1. Synthesis and characterizations of zinc (II) complexes
The Schiff bases 2HP and DHP were prepared according to
the procedure reported (Saleh et al., 2011) in our previous
work with some slight modiﬁcations. The zinc(II) complexes
are synthesized according to the following general procedure.
A solution of the Schiff base 2HP (0.25 g, 1 mmol) in meth-
anol (25 mL) was added to the equimolar solution of zinc(II)
chloride hydrate (0.14 g, 1 mmol) in methanol (25 mL) and
stirred at room temperature for 1 h. A light-yellow precipitate
was formed. The solid product (Zn2HP) was ﬁltered, washed
with absolute ethanol and dried in a vacuum. The solid
(Zn-2HP) was then dissolved in ethanol-chloroform mixture
(30:70) and after three days in the mother-liquor, it produces
yellow needle-like crystals of very poor quality. Recrystalliza-
tion was carried out in methanol-dichloromethane mixture
but the nature and quality of the crystals still remained. It
exhausted our effort to produce high quality crystals for
X-ray diffraction. Same procedure was applied for the prepa-
ration of ZnDHP complex.
2.2.2. Analysis of the complex [Zn(2HP)Cl2]
Empirical formula: C14H21Cl2N3OZn. Molecular weight:
383.65 g/mol. Yeild: (0.21 g, 54.8%). Anal. Cal. C, 43.83; H,
5.52; N, 10.95. Found: C, 42.13; H, 4.89; N, 10.52. IR (KBr,
cm1, t): 3492 (NH); 2961 (C–H); 1597 (iminic); 1460
(arC–C); 1305 (phenolate); 538 (M–O); 493 (M–N). 1H
NMR spectrum (DMSO-d6), d, ppm: 6.02–7.56 (m, 2H,
arH), 2.46 (d, 4H, 2CH2 aliphatic), 2.19 (t, 3H, ketoiminic).
13C NMR spectrum (DMSO-d6), d, ppm: 14.0 (CH3), 20.0
(CH2), 40.0 (DMSO-d6 + CH2), 45.0–55.0 (CH2), 116–172
aromatic (CH). UV–visible: 267 nm (17,157 mol1L cm1,
pﬁ p*). m/z: 383.03 (molecular ion peak), 381.02, 385.02.
2.2.3. Analysis of the complex [Zn(DHP)Cl2]
Empirical formula; C14H21Cl2N3O2Zn. Molecular weight;
399.65 gmol1. Yeild: (0.19 g, 47.6%). Anal. Cal. C, 42.07;
H, 5.30; N, 10.95. Found; C, 40.75; H, 5.09; N, 9.85. IR
(KBr, cm1, t): 3503 (NH); 2952 (C–H); 1594 (iminic); 1370
(arC–C); 1274 (phenolate); 537 (M–O); 459 (M–N). 1H
NMR spectrum (DMSO-d6), d, ppm: 2.08 (t, 3H, ketoiminic),
2.31 (d, 4H, 2CH2 aliphatic), 6.02–6.56 (m, 2H, arH).
13C
NMR spectrum (DMSO-d6), d, ppm: 14.0 (CH3), 19.5
(CH2), 40.0 (DMSO-d6 + CH2), 46.5–56.5 (CH2), 103–172
aromatic (CH). UV–visible: 260 nm (22037.9 mol1L cm1
pﬁ p*). m/z: 399.65 (molecular ion peak), 399.03, 397.03.
2.3. Ulcerogenic study
2.3.1. Study design
2.3.1.1. Sprague Dawley. Healthy adult rats of 7–8 weeks
weighing about 170–200 g were used throughout the study.
The rats were divided into nine major groups of ﬁve rats each.vities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl) ethylimi-
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tric lesions were induced by oral administration of absolute
ethanol (5 ml/kg) to the rats, which were fasted for 24 h before
the experiments, but had free access to water. This experiment
was approved by the Ethics Committee for the care and use of
laboratory animals organized by the University of Malaya,
Kuala Lumpur, Malaysia.
The experimental rats were assigned to their respective
groups as follows, Group I and II rats were given food and
water for 14 days, Group III rats were treated with omeprazole
(30 mg/kg) dissolved in carboxymethylcellulose (CMC) single
dose, Group IV and V received the Schiff bases 2HP and
DHP respectively at the dose of 30 mg/kg each, for 14 days.
Rats in Groups VI and VII were given Zn2HP 30 and
60 mg/kg correspondingly for two weeks, while rats in Groups
VIII and IX were orally administered with ZnDHP 30 and
60 mg/kg body weight respectively for 14 days. After two week
treatments with or without the compounds, the animals were
fasted for 24 h and on day 15, group III, received omeprazole,
Groups IV–IX were given the compounds according to the
ﬁxed doses whereby Group I and II received vehicle. One hour
after this treatment, animals in Group II–IX received aspirin
(600 mg/kg) dissolved in CMC orally. The animals were
sacriﬁced 8 h later by cervical decapitation under anesthetized
xylazine and ketamine to obtain serum for biochemical
analysis.
2.3.2. Determination of ulcerogenic effects
The rats were sacriﬁced under anesthesia (xylazine and keta-
mine, 5 ml/kg), the stomachs were excised and opened along
the greater curvature. Lesion area was determined by measur-
ing each lesion along its greatest diameter under a dissection
microscope (1.8·). The area of each ulcer lesion was measured
by counting the number of small squares (2 · 2 mm) covering
the length and width of each ulcer band. The sum of the le-
sions’ affected areas for each stomach was calculated and used
in the determination of ulcer area (UA mm2) and percent inhi-
bition (I %) (Mahmood et al., 2010). The ulcer score was ex-
pressed as square millimeters.
2.3.3. Serum evaluations
Blood samples collected from the experimental rats were cen-
trifuged at 4000 rpm for 10 min and analyzed for the changes
in serum enzymes AST, ALT and HDL using Hitachi-auto
analyzer at University Malaya Medical Center.
2.3.4. Cytokine evaluations
The level of pro-inﬂammatory (IL-6 and TNF-a) and anti-
inﬂammatory IL-10 cytokines in the serum of experimental
rats was assessed using ELISA kits for rats (Ray Biotech, Nor-
cross GA, USA) according to the manufacturer’s instructions.
Primary antibodies were ﬁrst coated on the well plate and after
washing, each well was blocked to remove the non-speciﬁc
binding. 100 lL of sample or cytokine standards was added
to each well and then followed with biotin conjugated second-
ary antibodies. To obtain a color reaction, streptavidin-HRP
and the substrate solution were added. The absorbance was
measured at 450 nm with an ELISA reader (TECAN, Manne-
dorf, Switzerland). Standard curves were plotted on each assay
plate using recombinant IL-6, IL-10, and TNF-a in serial
dilution.Please cite this article in press as: Salga, M.S. et al., Synthesis and gastroprotective acti
no)ethyl)phenol and (E)-4-(1-(2-(piperazin-1-yl) ethylimino)ethyl)benzene-1,3-diol Schiﬀ ba
dx.doi.org/10.1016/j.arabjc.2013.05.0282.3.5. Determination of Nitric Oxide (NO) level
The level of nitric oxide in the gastric tissue was evaluated as
total nitrate/nitrite levels using Gries’s reagent (Lanza et al.,
1980; Lopez-Belmonte et al., 1993). The gastric homogenate
in 50 mM potassium phosphate buffer (pH 7.8) was centri-
fuged at 4000 rpm for 30 min at 4 C. 50 lL of Gries’s reagent
(0.1% N-(1-naphthyl) ethylenediamide dihydrochloride, 1%
sulfanilamide in 5% phosphoric acid) was added to superna-
tant (50 lL) and mixed, then after 10 min the absorbance
was measured at 540 nm. The standard curves were obtained
by using sodium nitrite and expressed as micromoles nitrate/
nitrite per gram of protein.
2.3.6. Evaluation of malondialdehyde (MDA)
The level of malondialdehyde was estimated using the thiobar-
bituric acid-reactive substance (as indicators of lipid peroxida-
tion) assay according to the reported procedure (D’Argenio
et al., 2008; Hung, 2004) with some modiﬁcations. A solution
containing 26 mM thiobarbituric acid, 0.26 M hydrochloric
acid, 15% trichloric acid and 0.02% butylated hydroxyl tolu-
ene was prepared and stocked. A portion of this solution
(0.125 mL) was added to the stomach homogenates, heated
at 96 C for 15 min and centrifuged at 4000 rpm for 10 min.
The supernatant was transferred to the 96-well plate, and the
absorption was measured at 532 nm using tetramethoxypro-
pane as standard.
2.3.7. Histological evaluations
Histological evaluations were performed to estimate the extent
at which the ethanol damages the gastric mucosa. The pieces of
tissue samples were prepared and placed in 10% buffered for-
malin for processing in a Parafﬁn Tissue Processing Machine.
Sections of the gastric were made at a thickness of 5 lM and
stained with hematoxylin and eosin for histological
evaluations.
2.3.8. Statistical analysis
All values were reported as mean ± S.E.M. The signiﬁcant
differences between groups were assessed using one-way
ANOVA. A value of p < 0.05 was considered signiﬁcant.
3. Results and discussion
3.1. Synthesis and characterizations of zinc(II) complexes
In this study, a reﬂux condensation reaction was used to syn-
thesize the complexes of zinc (II) chloride. Treatment of meth-
anolic solution (25 mL) of the Schiff bases (E)-2-(1-(2-
(piperazin-1-yl)ethylimino)ethyl)phenol (2HP) and (E)-4-(1-
(2-(piperazin-1-yl)ethylimino)ethyl) benzene-1,3-diol (DHP)
with the solution of zinc(II) chloride in methanol (25 mL) re-
sulted in the formation of complexes Zn2HP and ZnDHP,
respectively. The compounds demonstrated MS, CHN,
NMR, IR, UV–visible and TGA consistent with the targeted
structure shown in Scheme 1. Compounds containing the
imine group in their structure were reported to have E/Z geo-
metrical isomers relative to AN‚CHA double bond based on
the solvent used (Demirbas et al., 2004). Examination of 1H
NMR spectra of both complexes revealed deﬁnite chemical
shift signals for AN‚CHA which was shielded by the methylvities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl) ethylimi-
ses against aspirin induced ulceration. Arabian Journal of Chemistry (2013), http://
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Scheme 1 Synthetic pathway for the complexes Zn2HP and ZnDHP.
4 M.S. Salga et al.group of the ketoimine and appeared once. This is in agree-
ment with the report that higher percentage of imine-contain-
ing compounds in dimethyl sulfoxide-d6 (DMSO-d6) solution
is present in the form of geometrical E isomer about
AN‚CHA double bond (Demirbas et al., 2004). The phenolic
hydrogen observed at d 7.6 and d 10.95 in the spectra of the
free Schiff bases 2HP and DHP had shifted to d 8.01 and d
7.16 in their zinc (II) complexes due to the chelate formation
(Figs. 1–4). The characteristic IR bands of Zn (II) complexes
derived from 2HP and DHP showed frequency bands atPlease cite this article in press as: Salga, M.S. et al., Synthesis and gastroprotective acti
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dx.doi.org/10.1016/j.arabjc.2013.05.0281597 and 1594 cm1 for m(iminic) and at 3492 and 3503 cm1
for m(phenolate). These bands were observed at the frequencies
of 1616 and 1610 cm1 for m(iminic) and 3394 and 3371 cm1 for
m(phenolic), in the spectra of the free Schiff bases (Figs. 5–8). This
is evidenced for the bonding of zinc with imine nitrogen and
phenolate oxygen (Shama and Omara, 2001). The UV–visible
of the complexes Zn2HP and ZnDHP recorded in DMSO
solvent showed absorption at the band regions 267 and
260 nm which can be assigned to pﬁ p* electronic transition
in the phenolic ring (Refat et al., 2008; Roncali, 1997). Thesevities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl) ethylimi-
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Figure 1 1H NMR spectra for [Zn(2HP)Cl2].
Figure 2 1H NMR spectra for [Zn(DHP)Cl2].
Synthesis and gastroprotective activities of some zinc (II) complexes derived from (E) 5absorptions were blue shifted from 318 to 283 nm in the
spectra of free Schiff bases and can be affordable to pﬁ p*
electronic transition originated from imine chromophore.
Moreover, the TGA curves for the complexes were recorded
from 50 to 900 C at 20 C intervals (Fig. 9) in order to deter-
mine the ﬁrst decomposition temperature of the compounds.
Both compounds exhibited two step decomposition with a
clearly separated ﬁrst step at 311 C in Zn2HP curve. The ob-Please cite this article in press as: Salga, M.S. et al., Synthesis and gastroprotective acti
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dx.doi.org/10.1016/j.arabjc.2013.05.028served mass loss corresponds to the departure of a molecule
with a relative molar mass of about 71 g/mol which can
presumably be attributed to the loss of one Cl2 molecule.
Furthermore, the compound ZnDHP showed its ﬁrst
decomposition at 269 C with a mass loss of 130.03 g. This
corresponds to the departure of one hydroxyl group and ethyl
piperazine molecules. Generally, the compounds showed high
thermal stability, which is required for this study.vities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl) ethylimi-
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Figure 4 13C NMR spectra for [Zn(DHP)Cl2].
Figure 3 13C NMR spectra for [Zn(2HP)Cl2].
6 M.S. Salga et al.3.2. Anti-ulcerogenic activity
The experimental animals pretreated with the compounds
2HP, DHP and their Zn(II) complexes for 14 days manifestedPlease cite this article in press as: Salga, M.S. et al., Synthesis and gastroprotective acti
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was substantiated by the ability of the compounds to safe
guard the mucosal integrity and enhanced the production of
nitric oxide synthase. The effective dose was chosen throughvities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl) ethylimi-
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Figure 5 IR-spectra of 2HP.
Figure 6 IR spectra of DHP.
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Figure 7 IR spectra for Zn-2HP.
Figure 8 IR spectra for Zn-DHP.
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Figure 9 Shows the TGA results for the complexes Zn2HP and
ZnDHP respectively. Both spectra (Zn2HP and ZnDHP) mani-
fested a distinct decomposition pattern at two steps and subse-
quently stabilized.
Synthesis and gastroprotective activities of some zinc (II) complexes derived from (E) 9the oral pilot dose selection of aspirin at 400 mg/kg administered
to the 12 and 24 h fasted rats. It was observed that this dose did
not signiﬁcantly induce ulcer even after 24 h of fasting. The dose
was then adjusted to 600 mg/kg and administered to 12 and 24 h
fasted rats. At this dose, few lesions and gastric bleeding were
observed after 12 h whereby severe lesions appeared in the
gastric of the rats fasted for 24 h. The parameters measured
from the gastric content of the rats treated with aspirin after
pretreatment with the Schiff bases 2HP, DHP and their zinc(II)
complexes are presented in (Table 1). The ulcerated animalsTable 1 Effects of the compounds on pH, mucus and gastric wall
Animals Pretreatment (5 ml/kg) Gastric pH
I Normal (CMC) 3.54 ± 1.6
II Aspirin (600 mg/kg) 0.98 ± 1.2
III Omeprazole (30 mg/kg) 3.46 ± 1.1
IV Ligand 2HP (30 mg/kg) 2.32 ± 2.3
V Ligand DHP (30 mg/kg) 2.45 ± 1.9
VI Zn-2HP (30 mg/kg) 3.79 ± 1.4
VII Zn-2HP (60 mg/kg) 4.62 ± 1.3
VIII ZnDHP (30 mg/kg) 4.64 ± 1.5
IX ZnDHP (60 mg/kg) 5.82 ± 1.5
Ulcer area (UA) = (mean + S.E.M),% I = percent inhibition.
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dx.doi.org/10.1016/j.arabjc.2013.05.028showed signiﬁcant rise in acidic pH and low mucus content
whereby the animals pretreated with the compounds exhibited
considerable inhibition of high stomach acidity and increased
mucus production dose dependently.
3.3. Gastric lesions
The compounds manifested protective activities against the
aspirin gastric ulceration dose-dependently as observed macro-
scopically after 8 h of ulcer induction (Fig. 10). The Schiff
bases 2HP and DHP had signiﬁcantly inhibited the gastric
injuries by 66.2% and 69.4%, respectively. However, this is be-
low the percentage inhibition of 82.43% shown by the refer-
enced drug (omeprazole). These inhibitory activities increase
dose-dependently in the zinc complexes of the Schiff bases to
83.11% in Zn2HP and to 85.95% in ZnDHP at low doses.
At high doses, a slight increase in the activity of the complexes
to 83.90% in Zn2HP and 86.73% in ZnDHP was noticed. This
result corresponds to the reported protective activities of the
free zinc (Sivalingam et al., 2011) and the observed activities
of the free Schiff bases in this study. The damage caused by
aspirin was identiﬁed macroscopically as areas of mucosal
hyperemia, leukocyte inﬁltrations and hemorrhagic lesions
with edema covering the total glandular area of the stomach
which was inferentially conﬁrmed by the histological assess-
ments of the gastric tissues.
3.4. Serum enzymes
The serum level of aspartate (AST), alanine aminotransamin-
ases (ALT), high-density lipoprotein (HDL) and energy stor-
age creatinine was assayed (Table 2). The liver enzymes AST
and ALT rise signiﬁcantly (p< 0.01) in rats that received aspi-
rin. This indicates damage to the liver cells. However, the rats
pretreated with the compounds showed no signiﬁcant varia-
tions in the level of such enzymes when compared with the rats
in the normal group. Also, the levels of creatinine and HDL in
the rats treated with the compounds are comparable with those
rats in the normal.
3.5. Cytokine assessments
The serum levels of pro-inﬂammatory cytokines such as tumor
necrosis factor alpha (TNF-a), interleukin-6 (IL-6) and anti-
inﬂammatory cytokine like interleukin-10 (IL-10) were
evaluated (Table 3). The rats pretreated with CMC aloneof the rats.
Mucus wt (g) UA (mm) % I
2.92 ± 1.6 0 0
1.39 ± 1.8 872.2 ± 9.2 –
3.08 ± 1.4 153.2 ± 7.9 82.43
2.97 ± 1.2 294.6 ± 2.4 66.22
2.98 ± 1.7 267.4 ± 2.2 69.34
3.69 ± 2.2 147.3 ± 4.2 83.11
4.31 ± 2.1 140.4 ± 3.8 83.90
3.82 ± 1.6 122.5 ± 4.2 85.95
4.89 ± 1.3 115.7 ± 5.1 86.73
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Figure 10 Gross gastric lesion: (A) Normal rats, (B) Aspirin induced ulcerated rats, 600 mg/KG, (C) Omeprazole (30 mg/kg, 82.43%,
(D) 2HP (30 mg/kg, 66.22%), (E) DHP (30 mg/kg, 69.34%), (F) Zn-2HP (30 mg/kg, 83.11%), (G) Zn-2HP (60 mg/kg, 83.90%), (H)
ZnDHP (30 mg/kg, 85.95%), and (I) ZnDHP (60 mg/kg, 86.73%).
Table 2 Effects of the compounds on serum biomarkers.
Animals ALT (IU/L) AST (IU/L) HDL Creatinine
I Normal (CMC) 68.47 ± 3.2 194.6 ± 5.2 1.93 ± 0.2 71.70 ± 4.1
II Aspirin (600 mg/kg) 88.42 ± 7.5 269.2 ± 8.1 0.04 ± 1.4 11.40 ± 1.3
III Omeprazole (30 mg/kg) 66.62 ± 3.1 178.8 ± 3.1 1.42 ± 0.4 57.70 ± 6.1
IV 2HP (30 mg/kg) 62.11 ± 2.3 165.2 ± 6.1 1.12 ± 0.9 42.20 ± 1.3
V DHP (30 mg/kg) 64.31 ± 4.3 167.4 ± 5.1 1.22 ± 0.4 49.40 ± 1.2
VI Zn2HP (30 mg/kg) 69.64 ± 5.3 182.3 ± 5.7 1.47 ± 0.6 59.20 ± 9.6
VII Zn2HP (60 mg/kg) 71.22 ± 3.2 188.3 ± 3.1 2.12 ± 0.9 64.30 ± 2.1
VIII ZnDHP (30 mg/kg) 70.46 ± 4.1 190.1 ± 2.1 2.20 ± 2.3 69.31 ± 1.8
IX ZnDHP (60 mg/kg) 72.32 ± 6.1 195.4 ± 1.6 2.62 ± 2.2 72.24 ± 1.5
10 M.S. Salga et al.showed a signiﬁcant increase in the level of pro-inﬂammatory
cytokines IL-6 and TNF-a and a decrease in the amount of
anti-inﬂammatory cytokine IL-10 whereby the rats pretreated
with the compounds showed high level of anti-inﬂammatory
cytokine IL-10.Please cite this article in press as: Salga, M.S. et al., Synthesis and gastroprotective acti
no)ethyl)phenol and (E)-4-(1-(2-(piperazin-1-yl) ethylimino)ethyl)benzene-1,3-diol Schiﬀ ba
dx.doi.org/10.1016/j.arabjc.2013.05.0283.6. Assessment of nitric oxide level
The animals pretreated with the compounds prior to aspirin
induced ulceration showed an increased level of nitric oxide
synthase (NO) (p< 0.05) (Table 3). This signiﬁes an enhance-vities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl) ethylimi-
ses against aspirin induced ulceration. Arabian Journal of Chemistry (2013), http://
Table 3 Effects of the compounds on MDA, NO, TNF-a, IL-6 and IL-10 in ulcerated rats.
Animals Treatments MDA (lmol/g tissue) NO (lmol) TNF-a (pg/mg) IL-6 (pg/mg) IL-10 (pg/mg)
I Normal (CMC) 13.21 ± 2.10 12.92 ± 1.20 0 0 245 ± 5.2
II Aspirin (600 mg/kg) 28.11 ± 1.40a 3.32 ± 0.06 386.0 ± 2.3 67.0 ± 2.1 72.0 ± 6.2
III Omeprazole (30 g/kg) 14.21 ± 1.20b 9.55 ± 0.12 112.0 ± 2.4 10.4 ± 1.5 264 ± 4.5
IV 2HP (30 mg/kg) 13.12 ± 1.10 c 9.13 ± 0.19 75.00 ± 2.1 15.30 ± 1.8 236 ± 3.3
V DHP (30 mg/kg) 13.21 ± 0.30 c 9.42 ± 0.65 81.50 ± 1.1 14.60 ± 1.6 245 ± 2.1
VI Zn2HP (30 mg/kg) 14.46 ± 1.23c 9.65 ± 1.20 123.2 ± 2.2 12.67 ± 1.1 253 ± 5.2
VII Zn2HP (60 mg/kg) 14.51 ± 1.31c 10.32 ± 1.13 129.8 ± 1.5 10.22 ± 1.4 278 ± 6.5
VIII ZnDHP (30 mg/kg) 14.87 ± 1.92 10.88 ± 3.20 133.2 ± 1.7 10.15 ± 1.7 283 ± 4.2
IX ZnDHP (60 mg/kg) 14.89 ± 2.10 11.92 ± 2.10 138.6 ± 1.5 8.21 ± 1.3 295 ± 5.1
Groups with different superscript alphabets are statistically signiﬁcant.
Figure 11 Histological view of gastric mucosa: (A) Normal (CMC), (B) Aspirin induced ulcerated rats, 600 mg/kg, (C) Omeprazole
(30 mg/kg, 82.43%, (D) 2HP (30 mg/kg, 66.22%), (E) DHP (30 mg/kg, 69.34%), (F) Zn-2HP (30 mg/kg, 83.11%), (G) Zn-2HP (60 mg/kg,
83.90%), (H) ZnDHP (30 mg/kg, 85.95%), and (I) ZnDHP (60 mg/kg, 86.73%).
Synthesis and gastroprotective activities of some zinc (II) complexes derived from (E) 11ment in the gastric defense by the compounds against the attack
of the ulcer model (Hutcheson et al., 1990). In contrast, the rats
that received aspirin alone showed an acute decrease inNO.This
displayed the damaging effects of aspirin in weakening the gas-
tric mucosal barrier (Cheung and Porterﬁeld, 1979; Fiorucci
et al., 2004; Whittle et al., 1990).Please cite this article in press as: Salga, M.S. et al., Synthesis and gastroprotective acti
no)ethyl)phenol and (E)-4-(1-(2-(piperazin-1-yl) ethylimino)ethyl)benzene-1,3-diol Schiﬀ ba
dx.doi.org/10.1016/j.arabjc.2013.05.0283.7. Level of MDA in tissue homogenate
The level of lipoperoxidation in the gastric of rats that are pre-
treated with CMC alone (5% in distilled water) was high
(28.11 ± 1.40 lmol of MDA/mg of tissue) when compared
with the observed lipoperoxidation (13.21 ± 2.1 lmol ofvities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl) ethylimi-
ses against aspirin induced ulceration. Arabian Journal of Chemistry (2013), http://
12 M.S. Salga et al.MDA/mg of tissue) in the normal rats. Furthermore, the stom-
achs of rats treated with 30 mg/kg of 2HP and DHP showed a
decreased level of MDA/mg in the tissue as 14.76 ± 1.23 and
14.57 ± 1.57 lmol respectively. This is bit high (p< 0.001)
than the value of 13.65 ± 1.31 and 13.89 ± 2.70 lmol ob-
served at the high dose of 60 mg/kg correspondingly. This
clearly indicates the ability of the compounds to reduce the le-
vel of lipoperoxidation signiﬁcantly (p< 0.001) at both doses
(Table 3).
3.8. Histological assessments
Histological evaluations of the gastric wall showed no signiﬁ-
cant changes between the rats pretreated with the compounds
and the rats in the normal groups (Fig. 10 A). The ulcerated
rats showed mucosal hyperemia and hemorrhagic lesions with
edema covering the total glandular area of the stomach
(Fig. 10B) which is a proof of acute ulceration (Choi et al.,
2010; Kraft et al., 1963; Lo et al., 1988). Pretreatment with
omeprazole and the compounds (30 and 60 mg/kg body weight
orally for 14 days) signiﬁcantly reduced the number of gastric
lesions (p< 0.05) (Fig. 10C–I) when compared with the ulcer
group (Fig. 10B). Furthermore, the expansion of gastric epi-
thelial cells, damage of mucosal design and predisposition of
exfoliation of gastric pits observed with ulcerated rats were
insigniﬁcant in the rats pre-treated with omeprazole
(Fig. 11C) and the compounds (Fig. 11D–I). Therefore, overall
histological scores revealed the protective efﬁcacies of the com-
pounds against aspirin induced ulceration by increasing the
tendency of restoration of the mucosa, reduced size of ulcer
crater and glandular organization.4. Conclusion
These ﬁndings suggest the protective efﬁcacies of zinc com-
plexes derived from the Schiff bases 2HP and DHP in protect-
ing the gastric mucosal cells against aspirin induced ulcers.
However, further investigations need to be conducted on these
novel compounds to exactly determine their chemotherapeutic
mechanism of action.Acknowledgments
The authors acknowledge the grants PS358/2009C and ER009-
2011A provided by the University of Malaya for the conduct
of this study.Please cite this article in press as: Salga, M.S. et al., Synthesis and gastroprotective acti
no)ethyl)phenol and (E)-4-(1-(2-(piperazin-1-yl) ethylimino)ethyl)benzene-1,3-diol Schiﬀ ba
dx.doi.org/10.1016/j.arabjc.2013.05.028References
Bertagnolli, M.M., 2003. J. Surg. Oncol. 84, 113–119.
Cheung, L.Y., Porterﬁeld, G., 1979. Am. J. Surg. 137, 106–110.
Choi, J., Raghavendran, H.R.B., Sung, N.Y., Kim, J.H., Chun, B.S.,
Ahn, D.H., Choi, H.S., Kang, K.W., Lee, J.W., 2010. Chem-Biol.
Interact. 183, 249–254.
D’Argenio, G., Mazzone, G., Tuccillo, C., Grandone, I., Gravina,
A.G., Graziani, G., Fogliano, V., Romano, M., 2008. Br. J. Nutr.
100, 1228–1236.
Demirbas, N., Karaoglu, S.A., Demirbas, A., Sancak, K., 2004. Eur. J.
Med. Chem. 39, 793–804.
Fiorucci, S., Di Lorenzo, A., Renga, B., Farneti, S., Morelli, A.,
Cirino, G., 2004. J. Pharmacol. Exp. Ther. 311, 1264–1271.
Gauthier, J.Y., Lau, C.K., LeBlanc, Y., Li, C.S., Roy, P., Therien, M.,
Wang, Z., 1996. Google Patents 5 (552), 422.
Hung, C.R., 2004. Inﬂammopharmacology 12, 115–129.
Hutcheson, I.R., Whittle, B.J., Boughton-Smith, N.K., 1990. Br. J.
Pharmacol. 101 (4), 815–820.
Johnstone, A.C., Lea, R.A., Brennan, K.A., Schenk, S., Kennedy,
M.A., Fitzmaurice, P.S., 2007. J. Psychopharmacol. 21, 888–894.
Kraft, S.C., Fitch, F.W., Kirsner, J.B., 1963. Am. J. Pathol. 43, 913–
927.
Lanza, F.L., Royer Jr, G.L., Nelson, R.S., 1980. N. Engl. J. Med. 303,
136–138.
Lo, S.K., Leung, F.W., Guth, P.H., 1988. Digest. Dis. Sci. 33, 1403–
1408.
Lopez-Belmonte, J., Whittle, B.J., Moncada, S., 1993. Br. J. Pharma-
col. 108, 73–78.
Mahmood, A.A., Mariod, A.A., Al-Bayaty, F., Abdel-Wahab, S.I.,
2010. J. Med. Plants Res. 4, 685–691.
Monnier, Y., Zaric, J., Ruegg, C., 2005. Curr. Drug Targets 4, 31–38.
Patrono, C., 1994. Aspirin as an antiplatelet drug. N. Engl. J. Med
330, 1287–1294.
Refat, M.S., El-Korashy, S.A., Kumar, D.N., Ahmed, A.S., 2008.
Spectrochim. Acta A 70, 898–906.
Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P., Hennekens,
C.H., 1997. N. Engl. J. Med 336, 973–979.
Roncali, J., 1997. Chem. Rev. 97, 173–206.
Saleh, M.S., Hapipah, M.A., Mahmood, A.A., Siddig, I.A., Lam,
K.W., Michael, J.C.B., Sri, D.S., Hamid, A.H.A., 2011. Molecules
16, 9316–9330.
Salga, M.S., Ali, H.M., Abdullah, M.A., Abdelwahab, S.I., Hussain,
P.D., A Hadi, H.A., 2011. Molecules 16, 8654–8669.
Shama, S.A., Omara, H., 2001. Spectrosc. Lett. 34, 49–56.
Sivalingam, N., Pichandi, S., Chapla, A., Dinakaran, A., Jacob, M.,
2011. Eur. J. Pharmacol. 654, 106–116.
Smith, J.B., Willis, A.L., 1971. Nature 231, 235–237.
Tuormaa, T.E., 1995. J. Orthomol. Med. 10, 149–164.
Vane, J.R., 1971. Nature 231, 232–235.
Whittle, B.J., Lopez-Belmonte, J., Moncada, S., 1990. Br. J. Pharma-
col. 99, 607–611.vities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl) ethylimi-
ses against aspirin induced ulceration. Arabian Journal of Chemistry (2013), http://
